Literature DB >> 3965240

Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate.

S H Curry, P I Chu, T G Baumgartner, P W Stacpoole.   

Abstract

Eleven healthy subjects received five doses of intravenous sodium dichloroacetate (DCA) at 2-hr intervals. Determinations of DCA in plasma and of lactate and glucose in blood were made at various times until 24 hr after starting the first infusion. Twenty-four-hour urinary oxalate excretion was also measured. DCA levels rose and fell during and after each dose, with higher levels induced by higher doses. Lactate levels fell as the result of DCA treatment, with greater falls after higher doses, and returned to normal after 24 hr at the two lower dose levels but not at the level of 50 mg/kg. Lactate levels did not change parallel to changes in DCA levels. Only the doses of 50 mg/kg prevented postprandial rises in lactate levels. Blood glucose levels were not altered. The mean DCA t1/2 after the initial doses was 63.3 min (range 15.0 to 112.2 min), while that after the final doses was 374.0 min (range 37.8 to 1386.0 min). The AUC and the DCA-induced increase in urinary oxalate excretion were linearly related to dose. Mean DCA apparent volume of distribution was 0.30 l/kg (range 0.09 to 0.60 l/kg).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965240     DOI: 10.1038/clpt.1985.17

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

Review 1.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

2.  Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.

Authors:  Edward B Garon; Heather R Christofk; Wylie Hosmer; Carolyn D Britten; Agnes Bahng; Matthew J Crabtree; Candice Sun Hong; Naeimeh Kamranpour; Sharon Pitts; Fairooz Kabbinavar; Cecil Patel; Erika von Euw; Alexander Black; Evangelos D Michelakis; Steven M Dubinett; Dennis J Slamon
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-18       Impact factor: 4.553

3.  A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.

Authors:  Zongchao Han; Kristen Berendzen; Li Zhong; Ira Surolia; Nitin Chouthai; Weihong Zhao; Njeri Maina; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2008-02-21       Impact factor: 4.797

4.  Haemodialysis studies with dichloroacetate.

Authors:  S H Curry; A Lorenz; G N Henderson; D R Mars; P W Stacpoole
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate.

Authors:  Peter W Stacpoole; Lesa R Gilbert; Richard E Neiberger; Paul R Carney; Edward Valenstein; Douglas W Theriaque; Jonathan J Shuster
Journal:  Pediatrics       Date:  2008-04-14       Impact factor: 7.124

Review 6.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

Review 7.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 8.  Targeting Cancer Metabolism - Revisiting the Warburg Effects.

Authors:  Quangdon Tran; Hyunji Lee; Jisoo Park; Seon-Hwan Kim; Jongsun Park
Journal:  Toxicol Res       Date:  2016-07-30

9.  The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein.

Authors:  Edward T Parkin; Jessica E Hammond; Lauren Owens; Matthew D Hodges
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

10.  Clinical pharmacology and toxicology of dichloroacetate.

Authors:  P W Stacpoole; G N Henderson; Z Yan; M O James
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.